Eric Lefebvre - Net Worth and Insider Trading
Eric Lefebvre Net Worth
The estimated net worth of Eric Lefebvre is at least $3 Million dollars as of 2024-12-26. Eric Lefebvre is the Chief Medical Officer of Pliant Therapeutics Inc and owns about 213,052 shares of Pliant Therapeutics Inc (PLRX) stock worth over $3 Million. Details can be seen in Eric Lefebvre's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Lefebvre has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Lefebvre
Eric Lefebvre Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Lefebvre owns 3 companies in total, including Pliant Therapeutics Inc (PLRX) , Regado Biosciences Inc (RGDO) , and CymaBay Therapeutics Inc (CBAY) .
Click here to see the complete history of Eric Lefebvre’s form 4 insider trades.
Insider Ownership Summary of Eric Lefebvre
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | Chief Medical Officer |
| RGDO | Regado Biosciences Inc | 2016-11-01 | Chief Medical Officer |
| CBAY | CymaBay Therapeutics Inc | 2022-03-21 | director |
Eric Lefebvre Latest Holdings Summary
Eric Lefebvre currently owns a total of 1 stock. Eric Lefebvre owns 213,052 shares of Pliant Therapeutics Inc (PLRX) as of July 10, 2024, with a value of $3 Million.
Latest Holdings of Eric Lefebvre
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLRX | Pliant Therapeutics Inc | 2024-07-10 | 213,052 | 13.49 | 2,874,071 |
Holding Weightings of Eric Lefebvre
Eric Lefebvre Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Lefebvre has made a total of 11 transactions in Pliant Therapeutics Inc (PLRX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Pliant Therapeutics Inc is the sale of 12,319 shares on July 10, 2024, which brought Eric Lefebvre around $142,408.
Insider Trading History of Eric Lefebvre
- 1
Eric Lefebvre Trading Performance
Eric Lefebvre Ownership Network
Eric Lefebvre Owned Company Details
What does Pliant Therapeutics Inc do?
Who are the key executives at Pliant Therapeutics Inc?
Eric Lefebvre is the Chief Medical Officer of Pliant Therapeutics Inc. Other key executives at Pliant Therapeutics Inc include Chief Business Officer Hans Hull , Chief Financial Officer Keith Lamont Cummings , and director & President and CEO Bernard Coulie .
Pliant Therapeutics Inc (PLRX) Insider Trades Summary
Over the past 18 months, Eric Lefebvre made 3 insider transaction in Pliant Therapeutics Inc (PLRX) with a net sale of 44,935. Other recent insider transactions involving Pliant Therapeutics Inc (PLRX) include a net sale of 72,542 shares made by Hans Hull , a net sale of 30,386 shares made by Mike Ouimette , and a net sale of 134,581 shares made by Bernard Coulie .
In summary, during the past 3 months, insiders sold 0 shares of Pliant Therapeutics Inc (PLRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,907 shares of Pliant Therapeutics Inc (PLRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,907 shares.
Pliant Therapeutics Inc (PLRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pliant Therapeutics Inc Insider Transactions
Eric Lefebvre Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Lefebvre. You might contact Eric Lefebvre via mailing address: C/o Tobira Therapeutics, Inc., 701 Gateway Boulevard, #200, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
